ID   NLRX1_RAT               Reviewed;         973 AA.
AC   Q5FVQ8;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2005, sequence version 1.
DT   07-APR-2021, entry version 105.
DE   RecName: Full=NLR family member X1;
DE   Flags: Precursor;
GN   Name=Nlrx1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Participates in antiviral signaling. {ECO:0000250}.
CC   -!- SUBUNIT: Homohexamer. Interacts with MAVS (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250}.
CC   -!- DOMAIN: The LRRCT domain mediates homodimerization and LRRNT mediates
CC       trimerization of the dimers. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the NLRP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC089834; AAH89834.1; -; mRNA.
DR   RefSeq; NP_001020181.1; NM_001025010.1.
DR   SMR; Q5FVQ8; -.
DR   STRING; 10116.ENSRNOP00000011620; -.
DR   iPTMnet; Q5FVQ8; -.
DR   PhosphoSitePlus; Q5FVQ8; -.
DR   jPOST; Q5FVQ8; -.
DR   PaxDb; Q5FVQ8; -.
DR   PRIDE; Q5FVQ8; -.
DR   GeneID; 315599; -.
DR   KEGG; rno:315599; -.
DR   UCSC; RGD:1311293; rat.
DR   CTD; 79671; -.
DR   RGD; 1311293; Nlrx1.
DR   eggNOG; KOG4308; Eukaryota.
DR   InParanoid; Q5FVQ8; -.
DR   OMA; NQPDCGC; -.
DR   OrthoDB; 114368at2759; -.
DR   Reactome; R-RNO-936440; Negative regulators of DDX58/IFIH1 signaling.
DR   PRO; PR:Q5FVQ8; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; ISO:RGD.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0045824; P:negative regulation of innate immune response; ISO:RGD.
DR   GO; GO:0032688; P:negative regulation of interferon-beta production; ISO:RGD.
DR   GO; GO:0032715; P:negative regulation of interleukin-6 production; ISO:RGD.
DR   GO; GO:0039536; P:negative regulation of RIG-I signaling pathway; ISO:RGD.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR007111; NACHT_NTPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF13516; LRR_6; 1.
DR   Pfam; PF05729; NACHT; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50837; NACHT; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Host-virus interaction; Immunity; Innate immunity;
KW   Leucine-rich repeat; Membrane; Mitochondrion; Mitochondrion outer membrane;
KW   Nucleotide-binding; Reference proteome; Repeat; Transit peptide.
FT   TRANSIT         1..84
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000250"
FT   CHAIN           85..973
FT                   /note="NLR family member X1"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000296192"
FT   DOMAIN          158..481
FT                   /note="NACHT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00136"
FT   DOMAIN          665..692
FT                   /note="LRRNT"
FT   REPEAT          693..716
FT                   /note="LRR 1"
FT   REPEAT          722..745
FT                   /note="LRR 2"
FT   REPEAT          747..775
FT                   /note="LRR 3"
FT   REPEAT          776..799
FT                   /note="LRR 4"
FT   REPEAT          809..832
FT                   /note="LRR 5"
FT   REPEAT          833..855
FT                   /note="LRR 6"
FT   REPEAT          856..875
FT                   /note="LRR 7"
FT   REPEAT          876..897
FT                   /note="LRR 8"
FT   DOMAIN          904..968
FT                   /note="LRRCT"
FT   NP_BIND         164..171
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00136"
FT   REGION          73..554
FT                   /note="Required for interaction with MAVS"
FT                   /evidence="ECO:0000250"
FT   REGION          554..972
FT                   /note="Required for the repression of MAVS-induced
FT                   interferon signaling"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   973 AA;  107590 MW;  73B87B5A1B70DE9F CRC64;
     MRWGCHLPRT SWGSGLGRTV PLPDELRIQS SWPFKGVHHP LRPPRAFIRH HGNSADSAPP
     PGRHGQLFRS ISATEAIQRH RRNLTEWFSR LPREERQFGP TFALDTVHVD PVIRESTPDD
     LLRPSTELAT GHQRTQAELP PLALSQLFDP DACGRRVQTV VLYGTVGTGK STLVRKMVLD
     WCYGRLPAFE LLIPFSCEDL SSLGSTPASL CQLVTQRYTP LKEVLPLMNA AGSRLLFVLH
     GLERLNLDFR LAGTGLCSDP EEPGAPAAIM VNLLRKYMLP EASILVTTRP SAIGRIPSKY
     VGRYGEICGF SDTNLQKLYF QLRLNQPDCG YGAGGTGVSV TPAQRDNLIQ MLSRNLEGHH
     QIAAACFLPS YCWLVCATLH FLHAPTSAGQ TLTSIYTSFL RLNFNGETLD STDPSNLSLM
     SYAARTMGKL AYEGVSSRKT YFSEEDVRGC LEAGIKTEEE FQLLQIFRRD ALRFFLAPCV
     EPGHLGTFVF TVPAMQEYLA ALYIVLGLRK TALQRVGKEV FEFVGRVGED VSLVLGIVAK
     LLPLRILPLL FNLLKVVPRV FGRMVSKSRE AVAQAMVLEM FREEDYYNDD VLDQMGASIL
     GVEGPRRHPD EPPEDEVFEL FPMFMSGLLS AHNRAVLAQL GCPIKNLDAL ENAQAIKKKL
     GKMGRQVLPP SELLDHLFFH YEFQNQRFSA EVLGSLRQLN LAGVRMTPLK CTVVASVLGS
     GRHPLDEVNL ASCQLDPAGL HTLMPVLLRA RKLGLQLNNL GPEACRDLRD LLLHDQCQIT
     TLRLSNNPLT AAGVGVLMDG LAGNTSVTHL SLLHTDLGDE GLELLAAQLD RNKQLQELNV
     AYNGAGDTVA LALAKAARKH PSLELLHLYF NELSSEGRQV LRDLGGSGEG GARVVASLTE
     GTAVSEYWSV ILSEVQRNLN SWDPVRVQRH LKLLLRDLED SRGATLNPWR KAQLLRVESE
     VKTLLEQLGG SGH
//
